APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Clinical Endpoint Assessment Software

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global AI Clinical Endpoint Assessment Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

12 August 2026194 pages

Choose your research edition.

Industry ResearchAI Clinical Endpoint Assessment Software Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Clinical Endpoint Assessment Software Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal AI Clinical Endpoint Assessment Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Clinical Endpoint Assessment Software Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Clinical Endpoint Assessment Software Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global AI Clinical Endpoint Assessment Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for AI Clinical Endpoint Assessment Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Clinical Endpoint Assessment Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Clinical Endpoint Assessment Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for AI Clinical Endpoint Assessment Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of AI Clinical Endpoint Assessment Software include IQVIA, ICON, Perceptive, Clinical Ink, Koneksa, AiCure, Medable, PathAI and Proscia, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global AI Clinical Endpoint Assessment Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Clinical Endpoint Assessment Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Clinical Endpoint Assessment Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI Clinical Endpoint Assessment Software market size, projected growth trends, production technologies, key applications, and end-use industries.

AI Clinical Endpoint Assessment Software Segment by Company

IQVIA

ICON

Perceptive

Clinical Ink

Koneksa

AiCure

Medable

PathAI

Proscia

Paige

IXICO

Median Technologies

VIDA Diagnostics

Image Analysis Group

QMENTA

Cambridge Cognition

Cogstate

Empatica

Cumulus Neuroscience

Rune Labs

VivoSense

NeuraLight

Aural Analytics

Linus Health

Quibim

Perspectum

Brainomix

Taimei Technology

UnionClin

XincereMed

Clario

Medidata

Signant Health

AI Clinical Endpoint Assessment Software Segment by Type

Medical Imaging Endpoints

Digital Pathology Endpoints

Electronic Clinical Outcome Assessment

Wearable and Physiological Endpoints

Voice, Video and Cognitive Endpoints

Multimodal Endpoints

AI Clinical Endpoint Assessment Software Segment by Application

Oncology

Neurology and Psychiatry

Cardiovascular and Metabolic Diseases

Respiratory Diseases

Musculoskeletal and Immunology

Other Therapeutic Areas

AI Clinical Endpoint Assessment Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Clinical Endpoint Assessment Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Clinical Endpoint Assessment Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Clinical Endpoint Assessment Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI Clinical Endpoint Assessment Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Clinical Endpoint Assessment Software industry.

Chapter 3: Detailed analysis of AI Clinical Endpoint Assessment Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Clinical Endpoint Assessment Softwarerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Medical Imaging Endpoints Table 3. Key Players of Digital Pathology Endpoints Table 4. Key Players of Electronic Clinical Outcome Assessment Table 3. Key Players of Wearable and Physiological Endpoints Table 4. Key Players of Voice, Video and Cognitive Endpoints Table 5. Key Players of Multimodal Endpoints Table 6. Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Oncology Table 8. Key Players of Neurology and Psychiatry Table 9. Key Players of Cardiovascular and Metabolic Diseases Table 10. Key Players of Respiratory Diseases Table 11. Key Players of Musculoskeletal and Immunology Table 12. Key Players of Other Therapeutic Areas Table 13. Global AI Clinical Endpoint Assessment Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global AI Clinical Endpoint Assessment Software Market Size by Region (2021-2026) & (US$ Million) Table 15. Global AI Clinical Endpoint Assessment Software Market Share by Region (2021-2026) Table 16. Global AI Clinical Endpoint Assessment Software Market Size by Region (2027-2032) & (US$ Million) Table 17. Global AI Clinical Endpoint Assessment Software Market Share by Region (2027-2032) Table 18. AI Clinical Endpoint Assessment Software Industry Trends Table 19. AI Clinical Endpoint Assessment Software Industry Drivers Table 20. AI Clinical Endpoint Assessment Software Industry Opportunities and Challenges Table 21. AI Clinical Endpoint Assessment Software Industry Restraints Table 22. Global AI Clinical Endpoint Assessment Software Revenue by Company (US$ Million) & (2021-2026) Table 23. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Company (2021-2026) Table 24. Global AI Clinical Endpoint Assessment Software Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 25. Global AI Clinical Endpoint Assessment Software Key Company Head Office and Area Served Table 26. Global AI Clinical Endpoint Assessment Software Company, Product Type & Application Table 27. Global AI Clinical Endpoint Assessment Software Company Establishment Date Table 28. Global Company Market Concentration Ratio (CR5 and HHI) Table 29. Global AI Clinical Endpoint Assessment Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 30. Global AI Clinical Endpoint Assessment Software Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI Clinical Endpoint Assessment Software Market Size by Type (2021-2026) & (US$ Million) Table 32. Global AI Clinical Endpoint Assessment Software Market Size by Type (2027-2032) & (US$ Million) Table 33. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Type (2021-2026) Table 34. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Type (2027-2032) Table 35. Global AI Clinical Endpoint Assessment Software Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global AI Clinical Endpoint Assessment Software Market Size by Application (2021-2026) & (US$ Million) Table 37. Global AI Clinical Endpoint Assessment Software Market Size by Application (2027-2032) & (US$ Million) Table 38. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Application (2021-2026) Table 39. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Application (2027-2032) Table 40. IQVIA Company Information Table 41. IQVIA Business Overview Table 42. IQVIA AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. IQVIA AI Clinical Endpoint Assessment Software Product Portfolio Table 44. IQVIA Recent Development Table 45. ICON Company Information Table 46. ICON Business Overview Table 47. ICON AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. ICON AI Clinical Endpoint Assessment Software Product Portfolio Table 49. ICON Recent Development Table 50. Perceptive Company Information Table 51. Perceptive Business Overview Table 52. Perceptive AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Perceptive AI Clinical Endpoint Assessment Software Product Portfolio Table 54. Perceptive Recent Development Table 55. Clinical Ink Company Information Table 56. Clinical Ink Business Overview Table 57. Clinical Ink AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Clinical Ink AI Clinical Endpoint Assessment Software Product Portfolio Table 59. Clinical Ink Recent Development Table 60. Koneksa Company Information Table 61. Koneksa Business Overview Table 62. Koneksa AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Koneksa AI Clinical Endpoint Assessment Software Product Portfolio Table 64. Koneksa Recent Development Table 65. AiCure Company Information Table 66. AiCure Business Overview Table 67. AiCure AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. AiCure AI Clinical Endpoint Assessment Software Product Portfolio Table 69. AiCure Recent Development Table 70. Medable Company Information Table 71. Medable Business Overview Table 72. Medable AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Medable AI Clinical Endpoint Assessment Software Product Portfolio Table 74. Medable Recent Development Table 75. PathAI Company Information Table 76. PathAI Business Overview Table 77. PathAI AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. PathAI AI Clinical Endpoint Assessment Software Product Portfolio Table 79. PathAI Recent Development Table 80. Proscia Company Information Table 81. Proscia Business Overview Table 82. Proscia AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Proscia AI Clinical Endpoint Assessment Software Product Portfolio Table 84. Proscia Recent Development Table 85. Paige Company Information Table 86. Paige Business Overview Table 87. Paige AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Paige AI Clinical Endpoint Assessment Software Product Portfolio Table 89. Paige Recent Development Table 90. IXICO Company Information Table 91. IXICO Business Overview Table 92. IXICO AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. IXICO AI Clinical Endpoint Assessment Software Product Portfolio Table 94. IXICO Recent Development Table 95. Median Technologies Company Information Table 96. Median Technologies Business Overview Table 97. Median Technologies AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Median Technologies AI Clinical Endpoint Assessment Software Product Portfolio Table 99. Median Technologies Recent Development Table 100. VIDA Diagnostics Company Information Table 101. VIDA Diagnostics Business Overview Table 102. VIDA Diagnostics AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. VIDA Diagnostics AI Clinical Endpoint Assessment Software Product Portfolio Table 104. VIDA Diagnostics Recent Development Table 105. Image Analysis Group Company Information Table 106. Image Analysis Group Business Overview Table 107. Image Analysis Group AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Image Analysis Group AI Clinical Endpoint Assessment Software Product Portfolio Table 109. Image Analysis Group Recent Development Table 110. QMENTA Company Information Table 111. QMENTA Business Overview Table 112. QMENTA AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. QMENTA AI Clinical Endpoint Assessment Software Product Portfolio Table 114. QMENTA Recent Development Table 115. Cambridge Cognition Company Information Table 116. Cambridge Cognition Business Overview Table 117. Cambridge Cognition AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Cambridge Cognition AI Clinical Endpoint Assessment Software Product Portfolio Table 119. Cambridge Cognition Recent Development Table 120. Cogstate Company Information Table 121. Cogstate Business Overview Table 122. Cogstate AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Cogstate AI Clinical Endpoint Assessment Software Product Portfolio Table 124. Cogstate Recent Development Table 125. Empatica Company Information Table 126. Empatica Business Overview Table 127. Empatica AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Empatica AI Clinical Endpoint Assessment Software Product Portfolio Table 129. Empatica Recent Development Table 130. Cumulus Neuroscience Company Information Table 131. Cumulus Neuroscience Business Overview Table 132. Cumulus Neuroscience AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. Cumulus Neuroscience AI Clinical Endpoint Assessment Software Product Portfolio Table 134. Cumulus Neuroscience Recent Development Table 135. Rune Labs Company Information Table 136. Rune Labs Business Overview Table 137. Rune Labs AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 138. Rune Labs AI Clinical Endpoint Assessment Software Product Portfolio Table 139. Rune Labs Recent Development Table 140. VivoSense Company Information Table 141. VivoSense Business Overview Table 142. VivoSense AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 143. VivoSense AI Clinical Endpoint Assessment Software Product Portfolio Table 144. VivoSense Recent Development Table 145. NeuraLight Company Information Table 146. NeuraLight Business Overview Table 147. NeuraLight AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 148. NeuraLight AI Clinical Endpoint Assessment Software Product Portfolio Table 149. NeuraLight Recent Development Table 150. Aural Analytics Company Information Table 151. Aural Analytics Business Overview Table 152. Aural Analytics AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 153. Aural Analytics AI Clinical Endpoint Assessment Software Product Portfolio Table 154. Aural Analytics Recent Development Table 155. Linus Health Company Information Table 156. Linus Health Business Overview Table 157. Linus Health AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 158. Linus Health AI Clinical Endpoint Assessment Software Product Portfolio Table 159. Linus Health Recent Development Table 160. Quibim Company Information Table 161. Quibim Business Overview Table 162. Quibim AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 163. Quibim AI Clinical Endpoint Assessment Software Product Portfolio Table 164. Quibim Recent Development Table 165. Perspectum Company Information Table 166. Perspectum Business Overview Table 167. Perspectum AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 168. Perspectum AI Clinical Endpoint Assessment Software Product Portfolio Table 169. Perspectum Recent Development Table 170. Brainomix Company Information Table 171. Brainomix Business Overview Table 172. Brainomix AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 173. Brainomix AI Clinical Endpoint Assessment Software Product Portfolio Table 174. Brainomix Recent Development Table 175. Taimei Technology Company Information Table 176. Taimei Technology Business Overview Table 177. Taimei Technology AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 178. Taimei Technology AI Clinical Endpoint Assessment Software Product Portfolio Table 179. Taimei Technology Recent Development Table 180. UnionClin Company Information Table 181. UnionClin Business Overview Table 182. UnionClin AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 183. UnionClin AI Clinical Endpoint Assessment Software Product Portfolio Table 184. UnionClin Recent Development Table 185. XincereMed Company Information Table 186. XincereMed Business Overview Table 187. XincereMed AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 188. XincereMed AI Clinical Endpoint Assessment Software Product Portfolio Table 189. XincereMed Recent Development Table 190. Clario Company Information Table 191. Clario Business Overview Table 192. Clario AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 193. Clario AI Clinical Endpoint Assessment Software Product Portfolio Table 194. Clario Recent Development Table 195. Medidata Company Information Table 196. Medidata Business Overview Table 197. Medidata AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 198. Medidata AI Clinical Endpoint Assessment Software Product Portfolio Table 199. Medidata Recent Development Table 200. Signant Health Company Information Table 201. Signant Health Business Overview Table 202. Signant Health AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 203. Signant Health AI Clinical Endpoint Assessment Software Product Portfolio Table 204. Signant Health Recent Development Table 205. North America AI Clinical Endpoint Assessment Software Market Size by Type (2021-2026) & (US$ Million) Table 206. North America AI Clinical Endpoint Assessment Software Market Size by Type (2027-2032) & (US$ Million) Table 207. North America AI Clinical Endpoint Assessment Software Market Size by Application (2021-2026) & (US$ Million) Table 208. North America AI Clinical Endpoint Assessment Software Market Size by Application (2027-2032) & (US$ Million) Table 209. North America AI Clinical Endpoint Assessment Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. North America AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026) Table 211. North America AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032) Table 212. Europe AI Clinical Endpoint Assessment Software Market Size by Type (2021-2026) & (US$ Million) Table 213. Europe AI Clinical Endpoint Assessment Software Market Size by Type (2027-2032) & (US$ Million) Table 214. Europe AI Clinical Endpoint Assessment Software Market Size by Application (2021-2026) & (US$ Million) Table 215. Europe AI Clinical Endpoint Assessment Software Market Size by Application (2027-2032) & (US$ Million) Table 216. Europe AI Clinical Endpoint Assessment Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. Europe AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026) Table 218. Europe AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032) Table 219. China AI Clinical Endpoint Assessment Software Market Size by Type (2021-2026) & (US$ Million) Table 220. China AI Clinical Endpoint Assessment Software Market Size by Type (2027-2032) & (US$ Million) Table 221. China AI Clinical Endpoint Assessment Software Market Size by Application (2021-2026) & (US$ Million) Table 222. China AI Clinical Endpoint Assessment Software Market Size by Application (2027-2032) & (US$ Million) Table 223. Asia AI Clinical Endpoint Assessment Software Market Size by Type (2021-2026) & (US$ Million) Table 224. Asia AI Clinical Endpoint Assessment Software Market Size by Type (2027-2032) & (US$ Million) Table 225. Asia AI Clinical Endpoint Assessment Software Market Size by Application (2021-2026) & (US$ Million) Table 226. Asia AI Clinical Endpoint Assessment Software Market Size by Application (2027-2032) & (US$ Million) Table 227. Asia AI Clinical Endpoint Assessment Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 228. Asia AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026) Table 229. Asia AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032) Table 230. South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Type (2021-2026) & (US$ Million) Table 231. South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Type (2027-2032) & (US$ Million) Table 232. South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Application (2021-2026) & (US$ Million) Table 233. South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Application (2027-2032) & (US$ Million) Table 234. South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 235. South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026) Table 236. South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032) Table 237. Research Programs/Design for This Report Table 238. Authors List of This Report Table 239. Secondary Sources Table 240. Primary Sources List of Figures Figure 1. AI Clinical Endpoint Assessment Software Product Image Figure 2. Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global AI Clinical Endpoint Assessment Software Market Share by Type: 2025 VS 2032 Figure 4. Medical Imaging Endpoints Image Figure 5. Digital Pathology Endpoints Image Figure 6. Electronic Clinical Outcome Assessment Image Figure 7. Wearable and Physiological Endpoints Image Figure 8. Voice, Video and Cognitive Endpoints Image Figure 9. Multimodal Endpoints Image Figure 10. Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global AI Clinical Endpoint Assessment Software Market Share by Application: 2025 VS 2032 Figure 12. Oncology Image Figure 13. Neurology and Psychiatry Image Figure 14. Cardiovascular and Metabolic Diseases Image Figure 15. Respiratory Diseases Image Figure 16. Musculoskeletal and Immunology Image Figure 17. Other Therapeutic Areas Image Figure 18. Global AI Clinical Endpoint Assessment Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 20. Global AI Clinical Endpoint Assessment Software Market Share by Region: 2025 VS 2032 Figure 21. Years Considered Figure 22. Global AI Clinical Endpoint Assessment Software Market Share by Players in 2025 Figure 23. Global Top 5 and 10 AI Clinical Endpoint Assessment Software Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Global AI Clinical Endpoint Assessment Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Type (2021-2032) Figure 27. Global AI Clinical Endpoint Assessment Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Application (2021-2032) Figure 29. North America AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 30. North America AI Clinical Endpoint Assessment Software Market Share by Type (2021-2032) Figure 31. North America AI Clinical Endpoint Assessment Software Market Share by Application (2021-2032) Figure 32. North America AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032) Figure 33. United States AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 34. Canada AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 35. Mexico AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 36. Europe AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 37. Europe AI Clinical Endpoint Assessment Software Market Share by Type (2021-2032) Figure 38. Europe AI Clinical Endpoint Assessment Software Market Share by Application (2021-2032) Figure 39. Europe AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032) Figure 40. Germany AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 41. France AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 42. U.K. AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 43. Italy AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 44. Russia AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 45. Nordic Countries AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 46. China AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 47. China AI Clinical Endpoint Assessment Software Market Share by Type (2021-2032) Figure 48. China AI Clinical Endpoint Assessment Software Market Share by Application (2021-2032) Figure 49. Asia AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 50. Asia AI Clinical Endpoint Assessment Software Market Share by Type (2021-2032) Figure 51. Asia AI Clinical Endpoint Assessment Software Market Share by Application (2021-2032) Figure 52. Asia AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032) Figure 53. Japan AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 54. South Korea AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 55. Taiwan AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 56. Southeast Asia AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 57. India AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 58. Australia AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 59. South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 60. South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Share by Type (2021-2032) Figure 61. South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Share by Application (2021-2032) Figure 62. South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032) Figure 63. Brazil AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 64. South Africa AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 65. Saudi Arabia AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 66. Turkey AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 67. Argentina AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 68. UAE AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 69. Egypt AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 70. Chile AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Medical Imaging Endpoints
  • Digital Pathology Endpoints
  • Electronic Clinical Outcome Assessment
  • Wearable and Physiological Endpoints
  • Voice, Video and Cognitive Endpoints
  • Multimodal Endpoints
Applications
  • Oncology
  • Neurology and Psychiatry
  • Cardiovascular and Metabolic Diseases
  • Respiratory Diseases
  • Musculoskeletal and Immunology
  • Other Therapeutic Areas
Companies covered
  • IQVIA
  • ICON
  • Perceptive
  • Clinical Ink
  • Koneksa
  • AiCure
  • Medable
  • PathAI
  • Proscia
  • Paige
  • IXICO
  • Median Technologies
  • VIDA Diagnostics
  • Image Analysis Group
  • QMENTA
  • Cambridge Cognition
  • Cogstate
  • Empatica
  • Cumulus Neuroscience
  • Rune Labs
  • VivoSense
  • NeuraLight
  • Aural Analytics
  • Linus Health
  • Quibim
  • Perspectum
  • Brainomix
  • Taimei Technology
  • UnionClin
  • XincereMed
  • Clario
  • Medidata
  • Signant Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Medical Imaging Endpoints
  5. 1.2.3 Digital Pathology Endpoints
  6. 1.2.4 Electronic Clinical Outcome Assessment
  7. 1.2.5 Wearable and Physiological Endpoints
  8. 1.2.6 Voice, Video and Cognitive Endpoints
  9. 1.2.7 Multimodal Endpoints
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Oncology
  13. 1.3.3 Neurology and Psychiatry
  14. 1.3.4 Cardiovascular and Metabolic Diseases
  15. 1.3.5 Respiratory Diseases
  16. 1.3.6 Musculoskeletal and Immunology
  17. 1.3.7 Other Therapeutic Areas
  18. 1.4 Global Market Growth Prospects
  19. 1.5 Global AI Clinical Endpoint Assessment Software Growth Trends by Region
  20. 1.5.1 Global AI Clinical Endpoint Assessment Software Market Size by Region: 2021 VS 2025 VS 2032
  21. 1.5.2 AI Clinical Endpoint Assessment Software Market Size by Region (2021-2026)
  22. 1.5.3 AI Clinical Endpoint Assessment Software Market Size by Region (2027-2032)
  23. 1.6 Assumptions and Limitations
  24. 1.7 Study Goals and Objectives
  25. 1.8 Years Considered
2 Global AI Clinical Endpoint Assessment Software Market Dynamics
  1. 2.1 AI Clinical Endpoint Assessment Software Industry Trends
  2. 2.2 AI Clinical Endpoint Assessment Software Industry Drivers
  3. 2.3 AI Clinical Endpoint Assessment Software Industry Opportunities and Challenges
  4. 2.4 AI Clinical Endpoint Assessment Software Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global AI Clinical Endpoint Assessment Software Revenue by Company (2021-2026)
  2. 3.2 Global AI Clinical Endpoint Assessment Software Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global AI Clinical Endpoint Assessment Software Key Company Head office and Area Served
  4. 3.4 Global AI Clinical Endpoint Assessment Software Company, Product Type & Application
  5. 3.5 Global AI Clinical Endpoint Assessment Software Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global AI Clinical Endpoint Assessment Software Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 AI Clinical Endpoint Assessment Software Players Market Share by Revenue in 2025
  9. 3.6.3 2025 AI Clinical Endpoint Assessment Software Tier 1, Tier 2, and Tier 3
4 AI Clinical Endpoint Assessment Software Market by Type
  1. 4.1 Global AI Clinical Endpoint Assessment Software Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global AI Clinical Endpoint Assessment Software Market Size by Type (2021-2032)
  3. 4.3 Global AI Clinical Endpoint Assessment Software Market Size Share by Type (2021-2032)
5 AI Clinical Endpoint Assessment Software Market by Application
  1. 5.1 Global AI Clinical Endpoint Assessment Software Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Clinical Endpoint Assessment Software Market Size by Application (2021-2032)
  3. 5.3 Global AI Clinical Endpoint Assessment Software Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 IQVIA
  2. 6.1.1 IQVIA Company Information
  3. 6.1.2 IQVIA Business Overview
  4. 6.1.3 IQVIA AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 IQVIA AI Clinical Endpoint Assessment Software Product Portfolio
  6. 6.1.5 IQVIA Recent Developments
  7. 6.2 ICON
  8. 6.2.1 ICON Company Information
  9. 6.2.2 ICON Business Overview
  10. 6.2.3 ICON AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 ICON AI Clinical Endpoint Assessment Software Product Portfolio
  12. 6.2.5 ICON Recent Developments
  13. 6.3 Perceptive
  14. 6.3.1 Perceptive Company Information
  15. 6.3.2 Perceptive Business Overview
  16. 6.3.3 Perceptive AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Perceptive AI Clinical Endpoint Assessment Software Product Portfolio
  18. 6.3.5 Perceptive Recent Developments
  19. 6.4 Clinical Ink
  20. 6.4.1 Clinical Ink Company Information
  21. 6.4.2 Clinical Ink Business Overview
  22. 6.4.3 Clinical Ink AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Clinical Ink AI Clinical Endpoint Assessment Software Product Portfolio
  24. 6.4.5 Clinical Ink Recent Developments
  25. 6.5 Koneksa
  26. 6.5.1 Koneksa Company Information
  27. 6.5.2 Koneksa Business Overview
  28. 6.5.3 Koneksa AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Koneksa AI Clinical Endpoint Assessment Software Product Portfolio
  30. 6.5.5 Koneksa Recent Developments
  31. 6.6 AiCure
  32. 6.6.1 AiCure Company Information
  33. 6.6.2 AiCure Business Overview
  34. 6.6.3 AiCure AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 AiCure AI Clinical Endpoint Assessment Software Product Portfolio
  36. 6.6.5 AiCure Recent Developments
  37. 6.7 Medable
  38. 6.7.1 Medable Company Information
  39. 6.7.2 Medable Business Overview
  40. 6.7.3 Medable AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Medable AI Clinical Endpoint Assessment Software Product Portfolio
  42. 6.7.5 Medable Recent Developments
  43. 6.8 PathAI
  44. 6.8.1 PathAI Company Information
  45. 6.8.2 PathAI Business Overview
  46. 6.8.3 PathAI AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 PathAI AI Clinical Endpoint Assessment Software Product Portfolio
  48. 6.8.5 PathAI Recent Developments
  49. 6.9 Proscia
  50. 6.9.1 Proscia Company Information
  51. 6.9.2 Proscia Business Overview
  52. 6.9.3 Proscia AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Proscia AI Clinical Endpoint Assessment Software Product Portfolio
  54. 6.9.5 Proscia Recent Developments
  55. 6.10 Paige
  56. 6.10.1 Paige Company Information
  57. 6.10.2 Paige Business Overview
  58. 6.10.3 Paige AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Paige AI Clinical Endpoint Assessment Software Product Portfolio
  60. 6.10.5 Paige Recent Developments
  61. 6.11 IXICO
  62. 6.11.1 IXICO Company Information
  63. 6.11.2 IXICO Business Overview
  64. 6.11.3 IXICO AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 IXICO AI Clinical Endpoint Assessment Software Product Portfolio
  66. 6.11.5 IXICO Recent Developments
  67. 6.12 Median Technologies
  68. 6.12.1 Median Technologies Company Information
  69. 6.12.2 Median Technologies Business Overview
  70. 6.12.3 Median Technologies AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Median Technologies AI Clinical Endpoint Assessment Software Product Portfolio
  72. 6.12.5 Median Technologies Recent Developments
  73. 6.13 VIDA Diagnostics
  74. 6.13.1 VIDA Diagnostics Company Information
  75. 6.13.2 VIDA Diagnostics Business Overview
  76. 6.13.3 VIDA Diagnostics AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 VIDA Diagnostics AI Clinical Endpoint Assessment Software Product Portfolio
  78. 6.13.5 VIDA Diagnostics Recent Developments
  79. 6.14 Image Analysis Group
  80. 6.14.1 Image Analysis Group Company Information
  81. 6.14.2 Image Analysis Group Business Overview
  82. 6.14.3 Image Analysis Group AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Image Analysis Group AI Clinical Endpoint Assessment Software Product Portfolio
  84. 6.14.5 Image Analysis Group Recent Developments
  85. 6.15 QMENTA
  86. 6.15.1 QMENTA Company Information
  87. 6.15.2 QMENTA Business Overview
  88. 6.15.3 QMENTA AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 QMENTA AI Clinical Endpoint Assessment Software Product Portfolio
  90. 6.15.5 QMENTA Recent Developments
  91. 6.16 Cambridge Cognition
  92. 6.16.1 Cambridge Cognition Company Information
  93. 6.16.2 Cambridge Cognition Business Overview
  94. 6.16.3 Cambridge Cognition AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Cambridge Cognition AI Clinical Endpoint Assessment Software Product Portfolio
  96. 6.16.5 Cambridge Cognition Recent Developments
  97. 6.17 Cogstate
  98. 6.17.1 Cogstate Company Information
  99. 6.17.2 Cogstate Business Overview
  100. 6.17.3 Cogstate AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Cogstate AI Clinical Endpoint Assessment Software Product Portfolio
  102. 6.17.5 Cogstate Recent Developments
  103. 6.18 Empatica
  104. 6.18.1 Empatica Company Information
  105. 6.18.2 Empatica Business Overview
  106. 6.18.3 Empatica AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Empatica AI Clinical Endpoint Assessment Software Product Portfolio
  108. 6.18.5 Empatica Recent Developments
  109. 6.19 Cumulus Neuroscience
  110. 6.19.1 Cumulus Neuroscience Company Information
  111. 6.19.2 Cumulus Neuroscience Business Overview
  112. 6.19.3 Cumulus Neuroscience AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Cumulus Neuroscience AI Clinical Endpoint Assessment Software Product Portfolio
  114. 6.19.5 Cumulus Neuroscience Recent Developments
  115. 6.20 Rune Labs
  116. 6.20.1 Rune Labs Company Information
  117. 6.20.2 Rune Labs Business Overview
  118. 6.20.3 Rune Labs AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Rune Labs AI Clinical Endpoint Assessment Software Product Portfolio
  120. 6.20.5 Rune Labs Recent Developments
  121. 6.21 VivoSense
  122. 6.21.1 VivoSense Company Information
  123. 6.21.2 VivoSense Business Overview
  124. 6.21.3 VivoSense AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 VivoSense AI Clinical Endpoint Assessment Software Product Portfolio
  126. 6.21.5 VivoSense Recent Developments
  127. 6.22 NeuraLight
  128. 6.22.1 NeuraLight Company Information
  129. 6.22.2 NeuraLight Business Overview
  130. 6.22.3 NeuraLight AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 NeuraLight AI Clinical Endpoint Assessment Software Product Portfolio
  132. 6.22.5 NeuraLight Recent Developments
  133. 6.23 Aural Analytics
  134. 6.23.1 Aural Analytics Company Information
  135. 6.23.2 Aural Analytics Business Overview
  136. 6.23.3 Aural Analytics AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Aural Analytics AI Clinical Endpoint Assessment Software Product Portfolio
  138. 6.23.5 Aural Analytics Recent Developments
  139. 6.24 Linus Health
  140. 6.24.1 Linus Health Company Information
  141. 6.24.2 Linus Health Business Overview
  142. 6.24.3 Linus Health AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 Linus Health AI Clinical Endpoint Assessment Software Product Portfolio
  144. 6.24.5 Linus Health Recent Developments
  145. 6.25 Quibim
  146. 6.25.1 Quibim Company Information
  147. 6.25.2 Quibim Business Overview
  148. 6.25.3 Quibim AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  149. 6.25.4 Quibim AI Clinical Endpoint Assessment Software Product Portfolio
  150. 6.25.5 Quibim Recent Developments
  151. 6.26 Perspectum
  152. 6.26.1 Perspectum Company Information
  153. 6.26.2 Perspectum Business Overview
  154. 6.26.3 Perspectum AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  155. 6.26.4 Perspectum AI Clinical Endpoint Assessment Software Product Portfolio
  156. 6.26.5 Perspectum Recent Developments
  157. 6.27 Brainomix
  158. 6.27.1 Brainomix Company Information
  159. 6.27.2 Brainomix Business Overview
  160. 6.27.3 Brainomix AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  161. 6.27.4 Brainomix AI Clinical Endpoint Assessment Software Product Portfolio
  162. 6.27.5 Brainomix Recent Developments
  163. 6.28 Taimei Technology
  164. 6.28.1 Taimei Technology Company Information
  165. 6.28.2 Taimei Technology Business Overview
  166. 6.28.3 Taimei Technology AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  167. 6.28.4 Taimei Technology AI Clinical Endpoint Assessment Software Product Portfolio
  168. 6.28.5 Taimei Technology Recent Developments
  169. 6.29 UnionClin
  170. 6.29.1 UnionClin Company Information
  171. 6.29.2 UnionClin Business Overview
  172. 6.29.3 UnionClin AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  173. 6.29.4 UnionClin AI Clinical Endpoint Assessment Software Product Portfolio
  174. 6.29.5 UnionClin Recent Developments
  175. 6.30 XincereMed
  176. 6.30.1 XincereMed Company Information
  177. 6.30.2 XincereMed Business Overview
  178. 6.30.3 XincereMed AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  179. 6.30.4 XincereMed AI Clinical Endpoint Assessment Software Product Portfolio
  180. 6.30.5 XincereMed Recent Developments
  181. 6.31 Clario
  182. 6.31.1 Clario Company Information
  183. 6.31.2 Clario Business Overview
  184. 6.31.3 Clario AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  185. 6.31.4 Clario AI Clinical Endpoint Assessment Software Product Portfolio
  186. 6.31.5 Clario Recent Developments
  187. 6.32 Medidata
  188. 6.32.1 Medidata Company Information
  189. 6.32.2 Medidata Business Overview
  190. 6.32.3 Medidata AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  191. 6.32.4 Medidata AI Clinical Endpoint Assessment Software Product Portfolio
  192. 6.32.5 Medidata Recent Developments
  193. 6.33 Signant Health
  194. 6.33.1 Signant Health Company Information
  195. 6.33.2 Signant Health Business Overview
  196. 6.33.3 Signant Health AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  197. 6.33.4 Signant Health AI Clinical Endpoint Assessment Software Product Portfolio
  198. 6.33.5 Signant Health Recent Developments
7 North America
  1. 7.1 North America AI Clinical Endpoint Assessment Software Market Size (2021-2032)
  2. 7.2 North America AI Clinical Endpoint Assessment Software Market Size by Type
  3. 7.2.1 North America AI Clinical Endpoint Assessment Software Market Size by Type (2021-2026)
  4. 7.2.2 North America AI Clinical Endpoint Assessment Software Market Size by Type (2027-2032)
  5. 7.2.3 North America AI Clinical Endpoint Assessment Software Market Share by Type (2021-2032)
  6. 7.3 North America AI Clinical Endpoint Assessment Software Market Size by Application
  7. 7.3.1 North America AI Clinical Endpoint Assessment Software Market Size by Application (2021-2026)
  8. 7.3.2 North America AI Clinical Endpoint Assessment Software Market Size by Application (2027-2032)
  9. 7.3.3 North America AI Clinical Endpoint Assessment Software Market Share by Application (2021-2032)
  10. 7.4 North America AI Clinical Endpoint Assessment Software Market Size by Country
  11. 7.4.1 North America AI Clinical Endpoint Assessment Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026)
  13. 7.4.3 North America AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032)
  14. 7.4.4 North America AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe AI Clinical Endpoint Assessment Software Market Size (2021-2032)
  2. 8.2 Europe AI Clinical Endpoint Assessment Software Market Size by Type
  3. 8.2.1 Europe AI Clinical Endpoint Assessment Software Market Size by Type (2021-2026)
  4. 8.2.2 Europe AI Clinical Endpoint Assessment Software Market Size by Type (2027-2032)
  5. 8.2.3 Europe AI Clinical Endpoint Assessment Software Market Share by Type (2021-2032)
  6. 8.3 Europe AI Clinical Endpoint Assessment Software Market Size by Application
  7. 8.3.1 Europe AI Clinical Endpoint Assessment Software Market Size by Application (2021-2026)
  8. 8.3.2 Europe AI Clinical Endpoint Assessment Software Market Size by Application (2027-2032)
  9. 8.3.3 Europe AI Clinical Endpoint Assessment Software Market Share by Application (2021-2032)
  10. 8.4 Europe AI Clinical Endpoint Assessment Software Market Size by Country
  11. 8.4.1 Europe AI Clinical Endpoint Assessment Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026)
  13. 8.4.3 Europe AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032)
  14. 8.4.4 Europe AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China AI Clinical Endpoint Assessment Software Market Size (2021-2032)
  2. 9.2 China AI Clinical Endpoint Assessment Software Market Size by Type
  3. 9.2.1 China AI Clinical Endpoint Assessment Software Market Size by Type (2021-2026)
  4. 9.2.2 China AI Clinical Endpoint Assessment Software Market Size by Type (2027-2032)
  5. 9.2.3 China AI Clinical Endpoint Assessment Software Market Share by Type (2021-2032)
  6. 9.3 China AI Clinical Endpoint Assessment Software Market Size by Application
  7. 9.3.1 China AI Clinical Endpoint Assessment Software Market Size by Application (2021-2026)
  8. 9.3.2 China AI Clinical Endpoint Assessment Software Market Size by Application (2027-2032)
  9. 9.3.3 China AI Clinical Endpoint Assessment Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia AI Clinical Endpoint Assessment Software Market Size (2021-2032)
  2. 10.2 Asia AI Clinical Endpoint Assessment Software Market Size by Type
  3. 10.2.1 Asia AI Clinical Endpoint Assessment Software Market Size by Type (2021-2026)
  4. 10.2.2 Asia AI Clinical Endpoint Assessment Software Market Size by Type (2027-2032)
  5. 10.2.3 Asia AI Clinical Endpoint Assessment Software Market Share by Type (2021-2032)
  6. 10.3 Asia AI Clinical Endpoint Assessment Software Market Size by Application
  7. 10.3.1 Asia AI Clinical Endpoint Assessment Software Market Size by Application (2021-2026)
  8. 10.3.2 Asia AI Clinical Endpoint Assessment Software Market Size by Application (2027-2032)
  9. 10.3.3 Asia AI Clinical Endpoint Assessment Software Market Share by Application (2021-2032)
  10. 10.4 Asia AI Clinical Endpoint Assessment Software Market Size by Country
  11. 10.4.1 Asia AI Clinical Endpoint Assessment Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026)
  13. 10.4.3 Asia AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032)
  14. 10.4.4 Asia AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Type
  3. 11.2.1 South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Application
  7. 11.3.1 South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country
  11. 11.4.1 South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst